drugset
drugset / Trial / NCT01436474

Pilot Study of Varenicline to Treat Opioid Dependence

NCT01436474 ↗

Phase 1 Completed 21 enrolled Mayo Clinic
RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of this proposal is to explore the potential of varenicline as a pharmacotherapeutic agent for opioid dependence and addiction.

Timeline

Start
2011-06
Primary completion
2012-09
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 1 mg Oral

Indications

chronic pain syndrome opiate dependence